← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Confluence Life Sciences, Llc
Saint Louis, MO
$1,039,077
Total funding
4
Grants
Funding over time
peak $299.9K · FY2013–17$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$1,039,077 · 4
By mechanism
R43$1,039,077 · 4
Investigators at Confluence Life Sciences, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
ITK inhibitors as an immunotherapeutic approach to colorectal cancer$299,949
R43 · FY2016 · CA
Development of TAK1 Inhibitors to Treat Pancreatic Cancer$289,278
R43 · FY2013 · CA
ITK/TXK Inhibitors as Oral Immunotherapeutic Drugs for Psoriasis$225,000
R43 · FY2017 · AR
Development of TAK1 Compounds for Neonatal Onset Multisystem Inflammatory Disease$224,850
R43 · FY2014 · AR